ABERA - Key Persons
Job Titles:
- Executive Chairman of the Board
- Member of the BOARD of DIRECTORS
Anders Ericson has worked in several positions within the financial industry for more than 18 years. He is the owner and CEO of Smallcap.se, which is a financial communications firm specializing in life science companies.
Job Titles:
- Member of the ADVISORY BOARD
- Research Director at French National Institute of Health
Dr Locht is currently Research Director at French National Institute of Health and Medical Research (Inserm) and Head of Center for Infection and Immunity of Lille, Institute Pasteur de Lille, France. Previously he held a scientific director role at GSK and has developed a nasal pertussis vaccine currently in clinical phase.
Job Titles:
- Member of the Board
- Member of the BOARD of DIRECTORS
Cristina Glad has an Executive MBA and PhD within Biochemistry. PhD Glad has over 30 years of experience in leading positions within biotech industry, eg. As Vice president at Bioinvent. PhD Glad has extensive experience of manufacturing operations, drug development, in and out licensing of projects, regulatory authorities and financing.
Florence Vicaire has over 25 years of experience in the life sciences sector and worked in Europe, Asia and US in global roles within marketing, sales, and business development. She also has experience as start-up founder and CEO within a successful MedTech business. Today she holds a position as Chief Commercial Officer at Univercells Technologies.
Born: 1971
Job Titles:
- Civil Engineer
- Member of the Board
- Member of the BOARD of DIRECTORS
Fredrik Juserius is a civil engineer with over 30 years of experience within Big Pharma in roles such as Country manager and Commercial director from e.g. GSK, Allergan and Takeda. Today, he holds the position at Country Director Nordics at Alexion. Mr. Juserius has sucessfully performed in and out licensing, M&A and business development within both vaccines and cancer.
Job Titles:
- Member of the Advisory Board
- Group Leader at the Dept
Prof. de Gier is group leader at the Dept. of Biochemistry and Biophysics of Stockholm University. His work focuses on the engineering of bacteria for recombinant protein production. Prof. de Gier co-founded the successful biotech company Xbrane Biopharma.
Job Titles:
- Member of the ADVISORY BOARD
PhD. van Beek is a Postdoctoral Researcher at Laboratory of Medical Immunology Radboud UMC focusing on pneumococcal infections and pneumococcal vaccine development. PhD. van Beek has collaborated with Abera for many years in the vaccine development program.
Maria Alriksson started her career within the pharma industry and she has extensive experience in people and project management, business development, change management and marketing from different industries. Former CEO of Xbrane Bioscience.
Born: 1983
Job Titles:
- Member of the ADVISORY BOARD
- Head of the Laboratory of Medical Immunology
Assoc. Prof. de Jonge is head of the Laboratory of Medical Immunology at Radboud UMC, the Netherlands. He is expert within mucosal immunization, respiratory disease and a long term collaborator with Abera around the pneumococcus vaccine development.
Mats has more than 25 years of experience in the field of vaccinology as well as research and development for new biopharmaceuticals. He holds a PhD in Immunology, Cell and Molecular Biology from the Karolinska Institute, and
extensive post-doc training at the MRC Clinical Sciences Centre, Imperial College School of Medicine in London, UK. In his industrial career Mats has had positions as scientist, manager, consultant and VP at Pharmacia, AstraZeneca and smaller biotech/vaccine companies. Prior to joining Abera he was the Applications Director at Cytiva/GE Healthcare and supported biopharma companies globally to develop and produce new vaccines and therapies more efficiently.
Born: 1965
Job Titles:
- CO - Founder
- CTO
- Our Founder and CTO
Our founder and CTO, Prof. Joen Luirink is a world-leading expert on bacterial protein trafficking and membrane transport systems and his vast knowledge in the area provided the basis for Abera's innovative vaccine delivery platform.
Prof. Luirink has more than 35 years of experience in Biochemistry and Molecular Microbiology and authored over 140 original scientific publications in peer-reviewed journals. Prof. Luirink specializes in protein trafficking in bacteria. He is currently head of the Department of Molecular Microbiology at VU University Amsterdam, and serves as the CTO of Abera.
Born: 1960 Shares in Abera: 583,332
Job Titles:
- Member of the Advisory Board
- Professor of Infection Biology
Prof. dr. Wagner is Professor of Infection Biology and Head of the Section of Cellular and Molecular Microbiology of the Eberhard Karls University Tübingen, Germany. He specializes in protein export pathways in pathogenic bacteria. Prof. dr. Wagner is a co-founder of Xbrane Biopharma.